15 articles for YJ Xu
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 3: Importance of the indole orientation.

Scios
Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 2: SAR of the amine tether.

Scios
Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 1: SAR of the aryl region.

Scios
Pyrimidine-based inhibitors of CaMKIIdelta.

Scios
Amide-based inhibitors of p38alpha MAP kinase. Part 1: discovery of novel N-pyridyl amide lead molecules.

Scios
Piperidine-based heterocyclic oxalyl amides as potent p38alpha MAP kinase inhibitors.

Scios
Discovery of RORγ Allosteric Fluorescent Probes and Their Application: Fluorescence Polarization, Screening, and Bioimaging.

Nanjing University of Chinese Medicine
Development of Long-Acting Dipeptidyl Peptidase-4 Inhibitors: Structural Evolution and Long-Acting Determinants.

Sichuan Normal University
1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors.

Imclone Systems
N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors.

Imclone Systems
Pyrimido-oxazepine as a versatile template for the development of inhibitors of specific kinases.

Imclone Systems
Indole-based heterocyclic inhibitors of p38alpha MAP kinase: designing a conformationally restricted analogue.

Scios
Discovery and development of novel rhodanine derivatives targeting enoyl-acyl carrier protein reductase.

Nanjing University
Discovery of 2-((3-cyanopyridin-2-yl)thio)acetamides as human lactate dehydrogenase A inhibitors to reduce the growth of MG-63 osteosarcoma cells: Virtual screening and biological validation.

Heilongjiang Province Hospital
Design and biological evaluation of novel triaryl pyrazoline derivatives with dioxane moiety for selective BRAF

Nanjing University